BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Johns Hopkins Technology Ventures - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Johns Hopkins Technology Ventures
X-ORIGINAL-URL:https://ventures.jhu.edu
X-WR-CALDESC:Events for Johns Hopkins Technology Ventures
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191113T120000
DTEND;TZID=America/New_York:20191113T130000
DTSTAMP:20191030T190733Z
CREATED:20191030T190733Z
LAST-MODIFIED:20191030T190733Z
UID:2779-1573646400-1573650000@ventures.jhu.edu
SUMMARY:Lunch & Learn with Thermo Fisher
DESCRIPTION:Enabling Technologies and Services for Faster\, More Cost-Effective Research \nGuest Speaker: Mark Federici \nDeveloping therapies for human disease continues to face obstacles in translating targets and compounds identified\, validated and optimized from in vitro studies to viable targets or efficacious and safe compounds once tested in humans. Here we discuss strategies to increase the relevance of cell models for these in vitro approaches by using primary cells coupled with various detection technologies for use in target identification and/or safety pharmacology. We review the current advances in genome engineering and how to leverage a portfolio of these tools to generate knock-out and knock-in models for use in target or compound identification. We extend that approach to its use with induced pluripotent stem cells (iPSCSs) to build isogenic disease models\, which can be further differentiated to various cell types of interest that are more directly related to a disease area than commonly used immortalized cell lines. \nIn this seminar\, we will present an executive level overview of Thermo Fisher’s Bioscience Division\, the biological capabilities and enabling technologies we provide\, as well as the services available across our diverse portfolio. We will also highlight our emerging 3D portfolio which contains cells\, medias\, scaffolds and instrumentation to support your organoid and spheroid culture R&D efforts. \nThermo Fisher will be providing equipment demos after the presentation. \nClick here to register.
URL:https://ventures.jhu.edu/event/lunch-learn-thermo-fisher-enabling-tech/
LOCATION:JHTV/FastForward\, 1812 Ashland Ave.\, 1812 Ashland Avenue\, Suite 110\, Baltimore\, MD\, 21205\, United States
END:VEVENT
END:VCALENDAR